IgVH mutations in blastoid mantle cell lymphoma characterize a subgroup with a tendency to more favourable clinical outcome

Journal of Pathology

Volumn 206, Issue 3, 2005, Pages 320-327

  Cogliatti, Sergio B ^a   Bertoni, Francesco ^b   Zimmermann, Dieter R ^c   Henz, Samuel ^a   Diss, Tim C ^d   Ghielmini, Michele ^b   Schmid, Ulrico ^a  

^a State Hospital   (Switzerland)

^b ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Blastoid mantle cell lymphoma; IgVH gene usage; IgVH somatic hypermutation; Prognosis

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BONE MARROW DISEASE; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DATA BASE; DISEASE COURSE; FEMALE; GENOTYPE; GERMINAL CENTER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LARGE CELL LYMPHOMA; MALE; MANTLE CELL LYMPHOMA; MUTATION RATE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SEQUENCE HOMOLOGY; SOMATIC HYPERMUTATION; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENES, IMMUNOGLOBULIN; GENOTYPE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; MUTATION; PROGNOSIS; SEQUENCE ANALYSIS, DNA; SURVIVAL ANALYSIS;

EID: 21344473914     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1781     Document Type: Article

References (30)

1. Gérard-Marchant R, Hamlin I, Lennert K, et al. Classification of non-Hodgkin's lymphomas [Letter to the Editor]. Lancet 1974;ii:406-408.
2. Weisenburger DD, Sanger WG, Armitage JO, et al. Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings. Blood 1987;69:1617-1621.
3. Banks PM, Chan J, Cleary ML, et al. Mantle cell lymphoma: a proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 1992;16:637-640.
4. Jaffe ES, Harris NL, Stein H, et al. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, 2001.
5. Campo E, Raffeld M, Jaffe ES. Mantle cell lymphoma. Semin Hematol 1999;36:115-127.
6. H genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood 1994;84:403-407.
7. Küppers R, Zhao M, Hansmann M-L, et al. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J 1993; 12:4955-4967.
8. Pittaluga S, Tierens A, Pinyol M, et al. Blastic variant of mantle cell lymphoma shows a heterogeneous pattern of somatic mutations of the rearranged immunoglobulin heavy chain variable genes. Br J Haematol 1998;102:1301-1306.
9. Hashimoto Y, Nakamura N, Kuze T, et al. Multiple lymphomatous polyposis of the gastrointestinal tract is a heterogeneous group that includes mantle cell lymphoma and follicular lymphoma: analysis of somatic mutation of immunoglobulin heavy chain gene variable region. Hum Pathol 1999;30:581-587.
10. H gene mutational analysis suggests that blastic variant of mantle cell lymphoma derives from different stages of B-cell maturation. Leuk Res 2000;24:27-31.
11. H genes and includes patients with good prognosis, nonnodal disease. Blood 2003;101:4975-4981.
12. H 3-21 use define new subsets of mantle cell lymphoma. Blood 2003; 101:4047-4054.
13. H genes and the frequency of somatic mutations. Blood 2003; 101:4042-4046.
14. H mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome. Blood 2003;102:3003-3009.
15. Bertoni F, Conconi A, Cogliatti SB, et al. Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22-23 deletion in classic mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research. Br J Hematol 2004; 124:289-298.
16. Du M-Q, Diss TC, Xu C-F, et al. Ongoing immunoglobulin gene mutations in mantle cell lymphomas. Br J Haematol 1997; 96:124-131.
17. Mepham BL, Frater W, Mitchell BS. The use of proteolytic enzymes to improve immunoglobulin staining by the PAP technique. Histochem J 1978;11:345-357.
18. Trainor KJ, Brisco MJ, Wan JH, et al. Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction. Blood 1991;78:192-196.
19. Diss TC, Pan L, Peng H, et al. Sources of DNA for detecting B cell monoclonality using PCR. J Clin Pathol 1994; 47:493-496.
20. Eick S, Krieger G, Bolz I, et al. Sequence analysis of amplified t(14;18) chromosomal breakpoints in B-cell lymphomas. J Pathol 1990;162:127-133.
21. Kneba M, Eick S, Herbst H, et al. Frequency and structure of t(14;18) major breakpoint regions in non-Hodgkin's lymphomas typed according to the Kiel classification: analysis by direct DNA sequencing. Cancer Res 1991;51:3243-3250.
22. Pinyol M, Campo E, Nadal A, et al. Detection of the bcl-1 rearrangement at the major translocation cluster in frozen and paraffin-embedded tissues of mantle cell lymphomas by polymerase chain reaction. Am J Clin Pathol 1996;105:532-537.
23. H genes with a moderate number of antigen-selected somatic mutations. Am J Pathol 1995; 147:1398-1407.
24. Klein U, Goossens T, Fischer M, et al. Somatic hypermutations in normal and transformed human B-cells. Immunol Rev 1998;162:261-280.
25. Lausen B, Schumacher M. Maximally selected rank statistics. Biometrics 1992;48:73-85.
26. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
27. Kaptain S, Zukerberg LR, Ferry JA, et al. Bcl-1/cyclin D1+ CD5- mantle cell lymphoma [abstract]. Mod Pathol 1998; 11:777.
28. Rosenwald A, Wright G, Wiestner A, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 2003;3:185-197.
29. H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002;100:1410-1416.
30. Martinez N, Camacho FI, Algara P, et al. The molecular signature of mantle cell lymphoma reveals multiple signals favouring cell survival. Cancer Res 2003;63:8226-8232.